Chronisch Lymphatische Leukämie Guidline and Quality indicator
0.2.0 - ci-build

Chronisch Lymphatische Leukämie Guidline and Quality indicator - Local Development build (v0.2.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

EvidenceVariable: Population: CLL und Binet Stadium AB

Active as of 2025-01-16

Generated Narrative: EvidenceVariable PopulationCLLBinetAB

url: EvidenceVariable Population: CLL und Binet Stadium AB

name: PopulationCLLBinetAB

title: Population: CLL und Binet Stadium AB

status: Active

date: 2025-01-16 09:02:23+0000

description:

Population, bei der Binet A oder B sowie eine bestimmte klinische Symptomatik vorliegt

actual: false

characteristic

definitionByCombination

code: All of

characteristic

linkId: CLL

DefinitionByTypeAndValues

-TypeValue[x]
*Clinical finding (finding)Chronic lymphoid leukaemia, disease

characteristic

definitionByCombination

code: Any of

characteristic

DefinitionByTypeAndValues

-TypeValue[x]
*Binet staging classification for chronic lymphocytic leukemiaClinical stage A chronic lymphocytic leukaemia

characteristic

DefinitionByTypeAndValues

-TypeValue[x]
*Binet staging classification for chronic lymphocytic leukemiaClinical stage B chronic lymphocytic leukaemia

characteristic

definitionByCombination

code: Any of

characteristic

linkId: CLL

DefinitionByTypeAndValues

-TypeValue[x]
*Clinical finding (finding)Weight decreasing

characteristic

linkId: CLL

DefinitionByTypeAndValues

-TypeValue[x]
*Clinical finding (finding)Pyrexia of unknown origin

characteristic

linkId: CLL

DefinitionByTypeAndValues

-TypeValue[x]
*Clinical finding (finding)Night sweats

characteristic

definitionByCombination

code: All of

characteristic

linkId: CLL

DefinitionByTypeAndValues

-TypeValue[x]
*Clinical finding (finding)Anemia

characteristic

linkId: CLL

DefinitionByTypeAndValues

-TypeValue[x]
*Hemoglobin [Mass/volume] in BloodDecreasing

characteristic

definitionByCombination

code: All of

characteristic

linkId: CLL

DefinitionByTypeAndValues

-TypeValue[x]
*Clinical finding (finding)Thrombocytopenic disorder

characteristic

linkId: CLL

DefinitionByTypeAndValues

-TypeValue[x]
*Platelets [#/volume] in BloodDecreasing

characteristic

definitionByCombination

code: All of

characteristic

DefinitionByTypeAndValues

-TypeValue[x]
*Clinical finding (finding)Poor response to corticosteroid treatment

characteristic

definitionByCombination

code: Any of

characteristic

linkId: CLL

DefinitionByTypeAndValues

-TypeValue[x]
*Clinical finding (finding)Autoimmune hemolytic anemia

characteristic

linkId: CLL

DefinitionByTypeAndValues

-TypeValue[x]
*Clinical finding (finding)Immune thrombocytopenia

characteristic

linkId: CLL

DefinitionByTypeAndValues

-TypeValue[x]
*Clinical finding (finding)Symptom-causing splenomegaly

characteristic

definitionByCombination

code: All of

characteristic

linkId: CLL

DefinitionByTypeAndValues

-TypeValue[x]
*Nodule size10-?

characteristic

linkId: CLL

DefinitionByTypeAndValues

-TypeValue[x]
*Clinical finding (finding)Lymphadenopathy

characteristic

definitionByCombination

code: All of

characteristic

linkId: CLL

DefinitionByTypeAndValues

-TypeValue[x]
*Nodule sizeIncreasing

characteristic

linkId: CLL

DefinitionByTypeAndValues

-TypeValue[x]
*Clinical finding (finding)Lymphadenopathy

characteristic

linkId: CLL

DefinitionByTypeAndValues

-TypeValue[x]
*Lymphocytes [#/volume] in BloodZunahme mehr als 50 Prozent innerhalb von 2 Monaten, gemessen ab einer absoluten Lymphozytenzahl von mindestens 30.000/µl

characteristic

linkId: CLL

DefinitionByTypeAndValues

-TypeValue[x]
*Lymphocytes [#/volume] in BloodLymphozytenverdopplungszeit unter 6 Monaten, gemessen ab einer absoluten Lymphozytenzahl von mindestens 30.000/µl